Insamo Therapeutics

Works on oral macrocyclic peptide drugs enabled by AI/ML and a trillion molecule display library

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Works on oral macrocyclic peptide drugs enabled by AI/ML and a trillion molecule display library.

02Backed By1 investor

03Recent Activity

Portfolio company Insamo launched with $12M in funding from Playground Global, venBio, and MRL Ventures Fund to develop macrocyclic peptide drugs.

MILESTONE·businesswire.com

FEB 21, 2024

04Similar Companies

PM

A

RP

GT

A

05Startup DNA

10

signals

Sectors
Business Model
Technology